<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37480299</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0974-7559</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Indian pediatrics</Title><ISOAbbreviation>Indian Pediatr</ISOAbbreviation></Journal><ArticleTitle>Association of Thrombotic Markers With Severity of Pediatric-Onset Systemic Lupus Erythematosus.</ArticleTitle><Pagination><StartPage>736</StartPage><EndPage>738</EndPage><MedlinePgn>736-738</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S097475591600565</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the relation of thrombotic markers, thrombomodulin and D-dimer levels to the disease severity in pediatric onset systemic lupus erythematosus (p-SLE) measured by the Systemic Lupus Erythematous Disease Activity Index (SLEDAI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">40 children with p-SLE were grouped according to SLEDAI into: low activity SLE group (laSLE) and moderate-high activity SLE group (mhaSLE). 40 healthy children were included as control group. Serum thrombomodulin, and D-dimer levels were measured for all enrolled children.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The low activity and moderate-high activity SLE groups had significantly higher mean (SD) thrombomodulin [7.2 (1.83) mg/mL and 9.86 (3.29) mg/mL, respectively vs 5.85 (1.41) mg/mL; P&lt;0.001] and D-dimer (r=0.42, P=0.006) levels than controls. Furthermore, the mhaSLE group had significantly higher thrombomodulin levels and D-dimer (r = 0.42, P= 0.006) levels than the laSLE group (P=0.008 and 0.006). Thrombomodulin and D-dimer had significant positive correlations with SLEDAI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Thrombomodulin and D-dimer are valuable markers for p-SLE activity, discriminating children with severe disease activity from those with low disease activity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maher</LastName><ForeName>Sheren Esam</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Minia University, El-Minya, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdul-Badia</LastName><ForeName>Ahmed Ragab</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Minia University, El-Minya, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu El-Ela</LastName><ForeName>Mostafa Ahmed</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Clinical Pathology, Faculty of Medicine, El-Minya, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mousa</LastName><ForeName>Suzan Omar</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, Minia University, El-Minya, Egypt. Correspondence to: Dr Suzan O Mousa, Department of Pediatric, Children's University hospital, Faculty of Medicine, Minia University, El-Minya, Egypt. suzanmousa@mu.edu.eg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian Pediatr</MedlineTA><NlmUniqueID>2985062R</NlmUniqueID><ISSNLinking>0019-6061</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018180">Thrombomodulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018180" MajorTopicYN="N">Thrombomodulin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>22</Day><Hour>21</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>22</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37480299</ArticleId><ArticleId IdType="pii">S097475591600565</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>